Enterade in Carcinoid/Non-Carcinoid Syndrome Neuroendocrine Tumor Patients With Quality of Life Limiting Bowel Frequency
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
This is an open-label phase II basket study evaluating the ability of enterade to reduce bowel frequency in neuroendocrine tumor (NET) patients with carcinoid syndrome and non-carcinoid syndrome.
创建时间：
2019-11-15
